Qianni Cheng, Ph.D. - Publications
Affiliations: | 2010 | The Chinese University of Hong Kong, Hong Kong, Hong Kong |
Area:
1. Drug resistant of pathogenic bacteria. 2. Molecular virology of HIV and HBV.Year | Citation | Score | |||
---|---|---|---|---|---|
2016 | Zhang D, So WY, Wang Y, Wu SY, Cheng Q, Leung PS. Insulinotropic effects of GPR120 agonists are altered in obese non-diabetic and diabetic states. Clinical Science (London, England : 1979). PMID 27980130 DOI: 10.1042/Cs20160545 | 0.306 | |||
2015 | So WY, Cheng Q, Xu A, Lam KS, Leung PS. Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice. Cell Death & Disease. 6: e1707. PMID 25811804 DOI: 10.1038/Cddis.2015.80 | 0.315 | |||
2015 | Chen L, So WY, Li SY, Cheng Q, Boucher BJ, Leung PS. Niacin-induced hyperglycemia is partially mediated via niacin receptor GPR109a in pancreatic islets. Molecular and Cellular Endocrinology. 404: 56-66. PMID 25622782 DOI: 10.1016/J.Mce.2015.01.029 | 0.324 | |||
2013 | So WY, Cheng Q, Chen L, Evans-Molina C, Xu A, Lam KS, Leung PS. High glucose represses β-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor γ signaling. Diabetes. 62: 3751-9. PMID 23897951 DOI: 10.2337/Db13-0645 | 0.32 | |||
2010 | Leung PS, Cheng Q. The novel roles of glucagon-like peptide-1, angiotensin II, and vitamin D in islet function. Advances in Experimental Medicine and Biology. 654: 339-61. PMID 20217505 DOI: 10.1007/978-90-481-3271-3_15 | 0.323 | |||
2008 | Cheng Q, Law PK, de Gasparo M, Leung PS. Combination of the dipeptidyl peptidase IV inhibitor LAF237 [(S)-1-[(3-hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with the angiotensin II type 1 receptor antagonist valsartan [N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl]-L-valine] enhances pancreatic islet morphology and function in a mouse model of type 2 diabetes. The Journal of Pharmacology and Experimental Therapeutics. 327: 683-91. PMID 18787107 DOI: 10.1124/Jpet.108.142703 | 0.322 | |||
Show low-probability matches. |